
Walter Kraft
, Program Director · Children's Hospital of Philadelphia
Credentials: · · · · ·
History
PresentOffice of Human Research Protection · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
PresentClinical Research Unit and Division of Clinical Pharmacology · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
- 1999–2000
- 1995–1996
Research
The Nephrotoxicity of Vancomycin
Review · Clinical Pharmacology & Therapeutics · 2017 · 316 citations
Archives of Otolaryngology - Head and Neck Surgery · 2010 · 120 citations
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome
New England Journal of Medicine · 2017 · First of 7 authors · 109 citations

16 papers

11 papers
- SA
11 papers
- DP
7 papers

5 papers

5 papers
- ME
5 papers

5 papers
Grants
- 1995–2030
Clinical Pharmacology Training Program
National Institute of General Medical Sciences · T32
Contact PI · $6.3M · Thomas Jefferson University
- 2025–2030
Clinical Pharmacology Training Program
National Institute of Child Health and Human Development · T32
Contact PI · $408.6K · Thomas Jefferson University
- 2021–2027
Thomas Jefferson University Hospital Clinical Site for HEAL NOWS Pharmacologic Trial
National Institute of Child Health and Human Development · UG1
Contact PI · $769.6K · Thomas Jefferson University
- 2011–2019
A Comparison of Buprenorphine Versus Morphine in the Treatment of the Neonatal Ab
National Institute on Drug Abuse · R01
Contact PI · $2.4M · Thomas Jefferson University
Clinical trials
- 2022
Principal investigator · Completed · Phase 1
Thomas Jefferson University
- 2020–2021
CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
Principal investigator · Terminated · Phase 2
Chiesi Farmaceutici S.p.A.
- 2020–2021
- 2020–2021
Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy
Principal investigator · Completed · Phase 1
Thomas Jefferson University
